However, ACAT1 inhibits glioma tumorigenesis through catalyzing glycine decarboxylase K514 acetylation (15), which suggests the role of ACAT1 in tumor progression is still a matter of debate and warrants further investigation (15). The gene discussed is GLDC; the disease is central nervous system cancer.